Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases.
Wenxian DuLingling ZhouQiang ZhangXin LiuXiaoer WeiYue-Hua LiPublished in: Molecules (Basel, Switzerland) (2021)
In the past few decades, brain diseases have taken a heavy toll on human health and social systems. Magnetic resonance imaging (MRI), photoacoustic imaging (PA), computed tomography (CT), and other imaging modes play important roles in disease prevention and treatment. However, the disadvantages of traditional imaging mode, such as long imaging time and large noise, limit the effective diagnosis of diseases, and reduce the precision treatment of diseases. The ever-growing applications of inorganic nanomaterials in biomedicine provide an exciting way to develop novel imaging systems. Moreover, these nanomaterials with special physicochemical characteristics can be modified by surface modification or combined with functional materials to improve targeting in different diseases of the brain to achieve accurate imaging of disease regions. This article reviews the potential applications of different types of inorganic nanomaterials in vivo imaging and in vitro detection of different brain disease models in recent years. In addition, the future trends, opportunities, and disadvantages of inorganic nanomaterials in the application of brain diseases are also discussed. Additionally, recommendations for improving the sensitivity and accuracy of inorganic nanomaterials in screening/diagnosis of brain diseases.
Keyphrases
- high resolution
- magnetic resonance imaging
- computed tomography
- human health
- resting state
- risk assessment
- healthcare
- systematic review
- magnetic resonance
- functional connectivity
- fluorescence imaging
- cerebral ischemia
- climate change
- blood brain barrier
- photodynamic therapy
- combination therapy
- drug delivery
- image quality
- current status
- dual energy
- diffusion weighted imaging